Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.

[1]  A. Ochiai,et al.  High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms. , 2000, Lung cancer.

[2]  S. Thomas,et al.  Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.

[3]  Roberta R. Miller.  Bronchioloalveolar Cell Adenomas , 1990, The American journal of surgical pathology.

[4]  K. Hiroshima,et al.  p53 Mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma , 1999, Cancer.

[5]  Y. Nishiwaki,et al.  Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers , 1980, The American journal of surgical pathology.

[6]  C. Crowson,et al.  Causes of death in patients with tuberous sclerosis. , 1991, Mayo Clinic proceedings.

[7]  K. Kerr,et al.  THE PATTERN OF K‐rasMUTATION IN PULMONARY ADENOCARCINOMA DEFINES A NEW PATHWAY OF TUMOUR DEVELOPMENT IN THE HUMAN LUNG , 1997, The Journal of pathology.

[8]  Kenji Suzuki,et al.  Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia , 1998, International journal of cancer.

[9]  R. Richards,et al.  Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16. , 1992, Genomics.

[10]  S. Petersen,et al.  Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. , 1997, Cancer research.

[11]  M. Sagawa,et al.  K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer. , 1998, British Journal of Cancer.

[12]  J. Minna,et al.  Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. , 1995, Journal of the National Cancer Institute.

[13]  U. Pastorino,et al.  Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. , 1992, Cancer research.

[14]  S. Hirohashi,et al.  Modified formalin and methanol fixation methods for molecular biological and morphological analyses , 1997, Pathology international.

[15]  Y. Takeshima,et al.  Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung. , 1998, Hiroshima journal of medical sciences.

[16]  J. Haines,et al.  A high-resolution linkage map of human 9q34.1. , 1993, Genomics.

[17]  Takaaki Ito,et al.  Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies , 1997, Virchows Archiv.

[18]  F. Capron,et al.  Pulmonary lymphangioleiomyomatosis and Bourneville's tuberous sclerosis with pulmonary involvement: The same disease? , 1983, Cancer.

[19]  R. Richards,et al.  Dinucleotide repeat polymorphisms at the D16S525, D16S359, D16S531 and D16S522 loci. , 1994, Human molecular genetics.

[20]  J. Minna,et al.  Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. , 1995, JAMA.

[21]  R. Hruban,et al.  K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. , 1996, Cancer research.

[22]  Y. Shimosato,et al.  Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. , 1986, American journal of clinical pathology.

[23]  W. Travis,et al.  Multifocal micronodular pneumocyte hyperplasia: a distinctive pulmonary manifestation of tuberous sclerosis. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[24]  J. Yokota,et al.  Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. , 1994, Cancer research.

[25]  H. Vinters,et al.  Micronodular pneumocyte hyperplasia. , 1998, The American journal of surgical pathology.

[26]  S Povey,et al.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. , 1997, Science.

[27]  R. Metcalf,et al.  p53 protein accumulates frequently in early bronchial neoplasia. , 1993, Cancer research.

[28]  Y. Inayama,et al.  Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. , 1996, The American journal of surgical pathology.

[29]  Y. Nishiwaki,et al.  The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. , 1997, Cancer.

[30]  I. Wistuba,et al.  Precursors to Pulmonary Neoplasia , 1998, Advances in anatomic pathology.